Overview of Zika virus (ZIKV) infection in regards to the Brazilian epidemic
Brazilian Journal of Medical and Biological Research (2016) 49(5): e5420, http://dx.doi.org/10.1590/1414-431X20165420
ISSN 1414-431X
Overview
1/11
Overview of Zika virus (ZIKV) infection in regards to
the Brazilian epidemic
S.N. Slavov1,2, K.K. Otaguiri1,3, S. Kashima1,3 and D.T. Covas1,2
1
Hemocentro de Ribeirão Preto, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
2
Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo,
Ribeirão Preto, SP, Brasil
3
Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas,
Universidade de São Paulo, Ribeirão Preto, SP, Brasil
Abstract
Zika virus (ZIKV), a mosquito-borne flavivirus, belongs to the Flaviviridae family, genus Flavivirus. ZIKV was initially isolated in
1947 from a sentinel monkey in the Zika forest, Uganda. Little clinical importance was attributed to ZIKV, once only few
symptomatic cases were reported in some African and Southeast Asiatic countries. This situation changed in 2007, when a
large outbreak was registered on the Yap Island, Micronesia, caused by the Asian ZIKV lineage. Between 2013 and 2014, ZIKV
spread explosively and caused many outbreaks in different islands of the Southern Pacific Ocean and in 2015 autochthonous
transmission was reported in Brazil. Currently, Brazil is the country with the highest number of ZIKV-positive cases in Latin
America. Moreover, for the first time after the discovery of ZIKV, the Brazilian scientists are studying the possibility for the virus
to cause severe congenital infection related to microcephaly and serious birth defects due to the time-spatial coincidence of the
alarming increase of newborns with microcephaly and the Brazilian ZIKV epidemic. The present review summarizes recent
information for ZIKV epidemiology, clinical picture, transmission, diagnosis and the consequences of this emerging virus in
Brazil.
Key words: Zika virus; ZIKV; Transmission; Epidemiology; Congenital infection; Brazil
Introduction
Zika virus (ZIKV) was isolated in 1947 from a febrile
sentinel Rhesus monkey from the Zika forest on the banks
of lake Victoria, Uganda (1). The virus was not linked to a
human infection until 1954, when ZIKV was detected in
three patients during an outbreak of jaundice in East
Nigeria (2). Almost at the same time, ZIKV has been
isolated from Aedes (Stegomya) africanus mosquitoes, in
Africa, and Aedes aegypti, in Southeast Asia (3,4). From
1954 to 1993 serologic evidence for ZIKV infection had
been reported from various African countries including
Kenya (5), Sierra Leone (6), Gabon (7,8), Ivory Coast (9),
Central African Republic (10), and Senegal (11). By this
time, in Asia, ZIKV has been detected in individuals with
acute fever from Central Java and Lombok Island,
Indonesia (12,13). This early serological evidence demonstrated that ZIKV circulates in some countries of SubSaharan Africa and Southeast Asia with relatively low
number of symptomatic cases (o10 official cases). The
situation changed in 2007, when an outbreak of a Dengue
virus (DENV)-like disease characterized by rash, conjunctivitis and arthralgia was registered on the Yap Island,
Micronesia (Figure 1). Rapid DENV tests suggested that it
was the etiological agent for that outbreak and the
collected samples were sent to the Centers for Disease
Control and Prevention (CDC) Arbovirus Diagnostic
Laboratory for viral confirmation. The performed tests with
Flaviviridae genus consensus primers demonstrated
sequences sharing 90% nucleotide identity with ZIKV.
Therefore, the Yap Island epidemic was caused by ZIKV
and not DENV and, specifically, by the ZIKV Asian lineage
(14). The Yap Island outbreak demonstrated that ZIKV
was not restricted to Africa and Southeast Asia and could
cause epidemics outside its habitual occurrence. Nevertheless, Micronesia is geographically close to the countries of Southeast Asia, where ZIKV is endemic and it
could be supposed that travelers or trade have introduced
the virus in Oceania. Surprisingly, between 2013 and
2014, ZIKV continued its spread through the Southern
Pacific and caused its largest outbreak in French
Polynesia with an estimated occurrence of 19,000 cases
in various islands from this region. The identified
genotype, similarly to the epidemic in the Yap Island,
Correspondence: S.N. Slavov: <>
Received March 21, 2016 | Accepted April 1, 2016
Braz J Med Biol Res | doi: 10.1590/1414-431X20165420
Overview of Zika virus (ZIKV)
belonged to the Asiatic lineage and its global expansion
was suspected (15). Moreover, the Asian lineage expanded
rapidly to many South Pacific islands and outbreaks were
reported from New Caledonia, the Cook Islands and the
Easter Island, Chile (16) (Figure 1).
The first official report for ZIKV autochthonous
transmission in Brazil was documented in March 2015 in
the city of Natal, in the Northeast part of the country. The
patients presented with a benign disease characterized by
mild fever, macopapular rash, headache, conjunctivitis,
arthralgia and edema, similar to the symptoms caused by
DENV, however all were DENV-negative (17). After
confirmation of autochthonous transmission of ZIKV in
Brazil, it was speculated that ZIKV entered the country
during the 2014 World Football Championship; however,
no countries endemic for ZIKV infection were competing in
this event. The most probable ZIKV introduction in Brazil
seems to have occurred during the Va’a World Sprint
Championship, where competitors from countries with ZIKV
outbreaks, i.e., French Polynesia, New Caledonia, Cook
Islands, and Easter Island, have been participating (18).
This event coincided with the first report of autochthonous
transmission of ZIKV in Brazil and with the confirmation of
the Asiatic lineage of the circulating strain. Currently, Brazil
is the country with the highest number of ZIKV-positive
cases in Latin America with circulation of the virus in almost
the entire national territory.
Viral characteristics
ZIKV belongs to the Flaviviridae family, genus Flavivirus,
closely related to the Spondweni virus (19). Therefore, ZIKV
has the typical flavivirus organization of the virion with an
icosahedral, enveloped particle. The genome is a singlestranded, positive-sense RNA of approximately 11 kb. The
genomic organization follows that of the flaviviruses with
two flanking non-coding regions (NCR), i.e. 59 and 39,
and a long open reading frame encoding a single polyprotein: (NCR59)-C-prM-E-NS1-NS2A-NS2BNS3-NS4A-NS4BNS5-(NCR39). The polyprotein is cleaved into capsid (C),
precursor of membrane (prM), envelope (E) and seven nonstructural proteins (NS) (20). The E protein, a major viral
envelope protein, is involved in receptor binding and
membrane fusion. The domain III of the E protein contains
different antigenic epitopes that may be important targets for
serological assays, neutralizing antibodies, and vaccines
(21). Worldwide dissemination of ZIKV is th (...truncated)